Prevalence of cardiac diastolic dysfunction in HIV-infected patients: results of the HIV-HEART study (Q42925866)

11 November 2017

Prevalence of cardiac diastolic dysfunction in HIV-infected patients: results of the HIV-HEART study (English)

1 reference

11 November 2017

1 reference

1 reference

7

Raimund Erbel

1 reference

11 November 2017

Nico Reinsch

1

1 reference

11 November 2017

Kathrin Neuhaus

2

1 reference

11 November 2017

Stefan Esser

3

1 reference

11 November 2017

Anja Potthoff

4

1 reference

11 November 2017

Martin Hower

5

1 reference

11 November 2017

Norbert H Brockmeyer

6

1 reference

11 November 2017

Till Neumann

8

1 reference

11 November 2017

German Competence Network for Heart Failure

9

1 reference

11 November 2017

German Competence Network for HIV AIDS

10

1 reference

11 November 2017

1 May 2010

1 reference

11 November 2017

1 reference

11 November 2017

11

1 reference

11 November 2017

3

1 reference

11 November 2017

156-162

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

11 November 2017

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-156

HIV-associated lipodystrophy: pathogenesis, prognosis, treatment, and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-156

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-156

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-156

Prevalence of left ventricular diastolic dysfunction in a general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-156

Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-156

Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-156

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-156

Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-156

New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-156

New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-156

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-156

Subclinical cardiac abnormalities in human immunodeficiency virus-infected men receiving antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-156

Cardiovascular risk and body-fat abnormalities in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-156

Use of HIV protease inhibitors is associated with left ventricular morphologic changes and diastolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-156

CD4+ count-guided interruption of antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-156

Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-156

Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-156

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-156

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-156

21 January 2018

Identifiers

DOI

10.1310/HCT1103-156

1 reference

11 November 2017

1 reference